Neurontin Lawsuit: Neurontin Off-Label Abuse Lawyer
Pfizer is currently marketing Neurontin as an oral medication for managing postherptic neuralgia, the pain that lingers after shingles has healed. This is an FDA-approved use, and studies have shown that Neurontin works to reduce patients' pain. It is a good drug, with many useful applications and few negative side effects, but it has a surprisingly long and sordid past.
Neurontin was originally approved in 1993 for the treatment of partial seizures in adults and children, especially epileptic seizures. However, this limited market for a drug with so few side effects was not enough for the company, Warner-Lambert. The company set up a massive campaign to improve sales of Neurontin, and it worked. By 2002 Neurontin was a $2 billion dollar drug, outselling even Viagra. How did a little epilepsy drug come to claim such a huge number of patients? It did so illicitly.
There are not enough patients suffering from epilepsy that one drug could earn profits of $2 billion a year. In order to claim these kinds of profits, Warner-Lambert began promoting the drug for off-label uses. The company sent representatives directly to doctors, urging them to prescribe Neurontin for to treat not only epilepsy but also bipolar disorder, alcohol withdrawal, cocaine abuse, HIV/AIDS neuropathy, phantom limb pain, anxiety, and a host of other diverse and unrelated conditions.
Though it has since been shown to work for some of these conditions, it was not clear at the time exactly what Neurontin did. The Warner-Lambert salesmen were lying to doctors about what Neurontin could do, and the doctors were listening. While it is illegal for a drug company to promote off-label uses directly and immoral to bribe doctors into prescribing a certain drug, it was also absolutely dangerous to claim Neurontin could cure disorders that it simply couldn't.
For example, Neurontin has no effect on bipolar disorder. Warner-Lambert sold thousands of doctors on the idea that Neurontin should be prescribed for bipolar disorder. If it did not work, they suggested increasing the dosage. One of the drug company managers told a salesman: "I don't want to see a single patient coming off Neurontin before they've been up to at least 4,800 milligrams a day. I don't want to hear that safety crap either.... It's a great drug." An untold number of bipolar patients were taken off their FDA-approved medication and prescribed Neurontin alone. Although Neurontin has few side effects, it also did nothing for their disorder, leaving these patients effectively unmedicated. Nobody knows how many lives were shattered as a result, but unmedicated bipolar disorder has a mortality rate of 55-60%.
Luckily for the public and patients taking Neurontin, a Warner-Lambert sales representative came forward and revealed the entire scandal. Pfizer has now purchased the Warner-Lambert Company, making Pfizer responsible for the injuries caused by the drug it now profits from. Lawsuits are being filed to claim damages for the dangerous corporate marketing strategies that have caused so much pain. If you or someone you love was wrongly administered Neurontin, please contact a lawyer and discuss your options.
To find out why you need a Neurontin lawyer and read articles about dangerous drugs and Neurontin side effects, visit our website at hugesettlements.com.
If you have any questions or concerns about filing a Neurontin lawsuit, please contact a professional Neurontin attorney right away!
Latest News
BioImagene CEO, Dr. Ajit Singh, Speaks On Enabling Personalized ... MarketWatch - Digital pathology, a key enabler for personalized medicine, will aid clinicians in managing and interpreting data from a whole new set of diagnostic tests ... Aperio Introduces SecondSlide(TM) Digital Slide Sharing Network |
![]() eFluxMedia | Medicine for the Job Market New York Times, United States - By JONATHAN GRUBER A CENTRAL feature of Barack Obama’s presidential campaign was an aggressive plan to expand health insurance coverage by subsidizing ... New Report Shows Slower Premium Growth, But Increasing Pressure to ... Health Corps Research database from the US Library of Medicine |
![]() eFluxMedia | American College of Surgeons Comments on Institute of Medicine ... MarketWatch - CHICAGO, Dec 03, 2008 /PRNewswire-USNewswire via COMTEX/ -- The American College of Surgeons (ACS) today recognized the Institute of Medicine (IOM) for its ... BMC Internal Medicine Residency Program Achieves National ... Report urges more sleep for medical residents Medical Residents Must Sleep After 16 Hours, Experts Urge |
Research and Markets: 2008 Integrative Medicine and Dietary ... MarketWatch - In this 32-page issue, we offer a breakdown of 2007 US Complementary and Alternative Medicine sales data and provides a detailed analysis of new integrative ... |
![]() Afrik.com | 34 Nigerian Children Dead From Tainted Medicine Voice of America - By VOA News Nigerian health officials say they are flying in doses of an antidote for a poisoned teething medicine that has now killed 34 infants. ... 'Toxic' syrup kills Nigerian babies Teething mixture kills more Nigerian babies Nigeria infant drug toll hits 34, antidote flown in |
Research database from the US Library of Medicine The Plain Dealer - cleveland.com, OH - Search PubMed, Clinicaltrials.gov, the CDC and a dozen other medical sites - all at once. AP MEDICAL VIDEO by Michael O'Malley and Joan Mazzolini/Plain ... |
A New Index of Preventive Medicine Companies Motley Fool - The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. ... |
American Academy of Dermatology Issues Position Statement on Vitamin D MarketWatch - The currently recommended adequate intake levels established by the Institute of Medicine may be revised upward due to evolving research on the increasing ... |
NIGERIA: Jos displaced grapple with food, water, medicine shortages IRINnews.org, NY - JOS, 4 December 2008 (IRIN) - Water, medicine and food supplies are running low for an estimated 10000 people displaced by violence in Jos, northern Nigeria ... |
![]() TheMedGuru | "Rogue" stem cell clinics exploit hope: report Reuters - "The direct-to-consumer portrayal of stem cell medicine is optimistic and unsupported by published evidence," Timothy Caulfield of the University of Alberta ... Scientists warn of “rogue” online stem cell clinics Internet stem-cell clinics 'exploiting' MS and Parkinson's patients The International Society for Stem Cell Research Releases New ... |
Resources
-
Sorry Currently Unavailable



